Non-inferiority/Similarity Margin

Jingyu Julia Luan, Wenyue Zhuo, Shein‐Chung Chow

Type: Book-Chapter

Publication Date: 2021-08-04

Citations: 0

DOI: https://doi.org/10.1201/9781003205807-9

View Publication

Locations

Chapman and Hall/CRC eBooks - View

Similar Works

Action	Title	Year	Authors
+	Statistical Methods for Assessment of Biosimilars	2022	Yafei Zhang Vivian Gu Xiuyu Julie Cong Shein‐Chung Chow
+ PDF Chat	Discussion about Points to Consider on Switching between Superiority and Non-inferiority & Guideline on the Choice of Non-inferiority Margin	2006	Nobuyuki Koyama
+	Issues on the selection of non-inferiority margin in clinical trials	2009	Yan Hou Xiaoyan Wu Kang Li
+	Equivalence Test with Flexible Margin	2021	Sang Joon Lee Minkyung Oh Shein‐Chung Chow
+	Non-inferiority studies: a methodological and regulatory perspective	2019	Turki A. Althunian
+	A Constrained Non-inferiority Approach for Assessing Clinical Efficacy to Establish Biosimilarity	2015	Jason J. Z. Liao
+	Statistical Methods for Assessing Biosimilarity	2017	Shein‐Chung Chow Fuyu Song
+ PDF Chat	A Reference Scaled Difference in Means Approach to Equivalence Test for Binary Clinical Outcomes	2024	Chao Wang
+ PDF Chat	Statistical considerations in biosimilar clinical efficacy trials with asymmetrical margins	2012	Yulan Li Qing Liu Patricia A. Wood A. Johri
+ PDF Chat	Essais de non-infériorité et d’équivalence : les points clés de leur méthodologie	2017	Marie Herr A. Descatha Philippe Aegerter
+ PDF Chat	Calculation of non-inferiority margin in pharmacoepidemiology: Simple methods for clinicians	2021	Kourosh Zali
+	Equivalence and non‐inferiority	2023	Richard Kay
+	A Further Look at the Current Equivalence Test for Analytical Similarity Assessment	2019	Neal Thomas Aili Cheng
+ PDF Chat	Statistical considerations for the development of biosimilar products	2014	Nan Zhang Eric Chi
+ PDF Chat	Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product	2017	Richard K. Burdick Neal Thomas Aili Cheng
+	Committee for medicinal products for human use (CHMP) guideline on the choice of the non‐inferiority margin	2006
+ PDF Chat	Sample Size Calculations for the Development of Biosimilar Products Based on Binary Endpoints	2015	Seung‐Ho Kang Ji-Yong Jung Seon-Hye Baik
+	Non-inferiority statistics and equivalence studies	2019	Jason M. Walker
+	Statistical considerations for confirmatory clinical trials for similar biotherapeutic products	2011	Catherine Njue
+ PDF Chat	Improving the power to establish clinical similarity in a Phase 3 efficacy trial by incorporating prior evidence of analytical and pharmacokinetic similarity	2017	Donglin Zeng Jean Pan Kuolung Hu Eric Chi D. Y. Lin

Works That Cite This (0)

Action	Title	Year	Authors

Works Cited by This (0)

Action	Title	Year	Authors